Directorio

Es posible que algunos contenidos no estén disponibles en español.
436 clinical trials found.
Hematologic Malignancies and Cellular Therapy

We are doing this study to test a device that tracks urine and stool output from people when they are in the hospital. This study is important because if the device works, it can improve patients' comfort while they are recovering from a stem cell transplant.

Compensation: No
Oncology
Lungs and Breathing

We are doing this to develop a test that could help predict a common complication after lung transplant called primary graft dysfunction (PGD). Examining the medical records of transplant recipients and their donors will help us find the data we need to create this prediction tool.

Compensation: No
Non-Oncology
Radiation Oncology

We are doing this study to measure quality of life and compare signs such as tiredness, feeling of unease, discomfort in the stomach, and pain in patients who have been treated with either PLA or HIGRT for liver cancer.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital, Other
Research for Healthy Adults

We created this registry to have a database of healthy people who are interested in participating in research about lung health and breathing. We will use this registry to reach out to people and notify them about research studies in which they might be interested.

Compensation: No
Ages: 18-110
Non-Oncology
Remote/online
Lungs and Breathing

We maintain this registry to have a database of people with any type of lung or breathing disorder who are interested in participating in research about their lung condition.

Compensation: No
Ages: 18-65
Non-Oncology
Duke University Hospital
Primary Brain and Spinal Cord Tumors

We are doing this study to find out how safe and effective an experimental drug called MVR-C5252 (the study drug) is for people with advanced brain cancer.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital
Eyes and Vision

We are doing this study to find out if an experimental drug called brepocitinib (the study drug) is a safe and effective option people with non-infectious uveitis (NIU).

Compensation: Yes
Ages: 18-75
Non-Oncology
Duke University Hospital
Research for Children and Teenagers

If you choose to join this study, we will ask you questions about:

  • Your life at home
  • Your life at school
  • Your medical needs
We will ask you to answer these questions each year during one of your regular clinic visits.

Compensation: No
Non-Oncology